开云app官网登录入口网页版-官方正版

#长期随访#

57篇内容 | 1549人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1967241, encodeId=70c6196e2417f, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=JCEM：有妊娠期糖尿病病史妇女发病率的长期随访, objectType=article, longId=736729, objectId=eca9e367298d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eca9e367298d, replyNumber=0, likeNumber=117, createdTime=2022-11-13, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eca9e367298d, moduleTitle=JCEM：有妊娠期糖尿病病史妇女发病率的长期随访, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=eca9e367298d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967240, encodeId=6eb8196e24014, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=Rheumatology：Janus激酶抑制剂和新型活动性疾病生物标记物在青少年皮肌炎中的长期随访结果, objectType=article, longId=734175, objectId=c505e341758a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c505e341758a, replyNumber=0, likeNumber=81, createdTime=2022-08-05, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c505e341758a, moduleTitle=Rheumatology：Janus激酶抑制剂和新型活动性疾病生物标记物在青少年皮肌炎中的长期随访结果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c505e341758a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967236, encodeId=e85c196e236bd, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=JNNP：急性功能性假性卒中与轻度急性缺血性卒中的长期随访比较, objectType=article, longId=219513, objectId=ccb92195139c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ccb92195139c, replyNumber=0, likeNumber=83, createdTime=2022-05-03, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ccb92195139c, moduleTitle=JNNP：急性功能性假性卒中与轻度急性缺血性卒中的长期随访比较, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ccb92195139c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967238, encodeId=a056196e23898, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=Acta Oncol：在临床试验之外接受治疗的慢性期老年慢性粒细胞白血病患者中一线达沙替尼的长期随访：一项现实生活中的队列观察研究, objectType=article, longId=294667, objectId=984729466e40, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=984729466e40, replyNumber=0, likeNumber=91, createdTime=2022-05-18, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=984729466e40, moduleTitle=Acta Oncol：在临床试验之外接受治疗的慢性期老年慢性粒细胞白血病患者中一线达沙替尼的长期随访：一项现实生活中的队列观察研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=984729466e40)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967239, encodeId=63b2196e239f1, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=Hypertension：长期随访血压变异性与亚临床肾损伤和蛋白尿的关系, objectType=article, longId=723446, objectId=3b0fe23446c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b0fe23446c7, replyNumber=0, likeNumber=83, createdTime=2023-03-19, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b0fe23446c7, moduleTitle=Hypertension：长期随访血压变异性与亚临床肾损伤和蛋白尿的关系, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3b0fe23446c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967230, encodeId=3a1b196e23008, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=EuroIntervention：肾动脉超声消融治疗难治性高血压长期随访结果公布（RADIANCE-HTN SOLO研究）, objectType=article, longId=214815, objectId=a05f2148157b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a05f2148157b, replyNumber=0, likeNumber=127, createdTime=2022-05-12, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a05f2148157b, moduleTitle=EuroIntervention：肾动脉超声消融治疗难治性高血压长期随访结果公布（RADIANCE-HTN SOLO研究）, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a05f2148157b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967233, encodeId=f2a8196e233e6, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=Clin Cancer Res：维奈托克单药治疗复发/难治性非霍奇金淋巴瘤的长期随访结果, objectType=article, longId=216691, objectId=f8e221669147, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8e221669147, replyNumber=0, likeNumber=64, createdTime=2022-02-28, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8e221669147, moduleTitle=Clin Cancer Res：维奈托克单药治疗复发/难治性非霍奇金淋巴瘤的长期随访结果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f8e221669147)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967237, encodeId=3580196e23767, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=长期随访显示，肾脏替代治疗伴急性肾损伤的感染性休克烧伤患者仍可长期保留肾功能, objectType=article, longId=293902, objectId=8f9f29390251, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f9f29390251, replyNumber=0, likeNumber=71, createdTime=2022-10-17, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f9f29390251, moduleTitle=长期随访显示，肾脏替代治疗伴急性肾损伤的感染性休克烧伤患者仍可长期保留肾功能, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8f9f29390251)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967235, encodeId=6404196e23527, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=Diabetes Care：多篇新发糖尿病患者长期随访研究提示，早期控糖真的很重要！, objectType=article, longId=218471, objectId=ff892184e1d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff892184e1d0, replyNumber=0, likeNumber=85, createdTime=2022-03-26, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff892184e1d0, moduleTitle=Diabetes Care：多篇新发糖尿病患者长期随访研究提示，早期控糖真的很重要！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ff892184e1d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967234, encodeId=21df196e234f4, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=Clin Cancer Res：3期coBRIM研究| 威罗非尼+帕博西尼治疗BRAFV600+ 晚期黑色素瘤的长期随访结果, objectType=article, longId=218363, objectId=b482218363b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b482218363b0, replyNumber=0, likeNumber=65, createdTime=2021-12-05, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b482218363b0, moduleTitle=Clin Cancer Res：3期coBRIM研究| 威罗非尼+帕博西尼治疗BRAFV600+ 晚期黑色素瘤的长期随访结果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b482218363b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967226, encodeId=ad67196e22628, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=Eur Urol Oncol：非肌层浸润性膀胱癌患者的长期随访及与主动监测失败相关的因素 , objectType=article, longId=212985, objectId=800a21298528, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=800a21298528, replyNumber=0, likeNumber=71, createdTime=2022-04-15, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=800a21298528, moduleTitle=Eur Urol Oncol：非肌层浸润性膀胱癌患者的长期随访及与主动监测失败相关的因素 , moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=800a21298528)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967228, encodeId=0115196e2287d, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=Clin Cancer Res: 考比替尼（cobimetinib）+ 维莫非尼（vemurafenib）对比安慰剂+ 维莫非尼（vemurafenib）治疗BRAF V600突变阳性转移性黑色素瘤的疗效和安全性: coBRIM研究5年长期随访结果, objectType=article, longId=213315, objectId=46ab21331526, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46ab21331526, replyNumber=0, likeNumber=67, createdTime=2021-07-27, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46ab21331526, moduleTitle=Clin Cancer Res: 考比替尼（cobimetinib）+ 维莫非尼（vemurafenib）对比安慰剂+ 维莫非尼（vemurafenib）治疗BRAF V600突变阳性转移性黑色素瘤的疗效和安全性: coBRIM研究5年长期随访结果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=46ab21331526)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967231, encodeId=19e5196e23147, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=Eur J Vas Endo Sur: 筛查中检测到主动脉直径25～29 mm的65岁男性建议长期随访主动脉扩张进程以确定是否需要手术修复, objectType=article, longId=215915, objectId=f754215915bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f754215915bf, replyNumber=0, likeNumber=71, createdTime=2022-05-28, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f754215915bf, moduleTitle=Eur J Vas Endo Sur: 筛查中检测到主动脉直径25～29 mm的65岁男性建议长期随访主动脉扩张进程以确定是否需要手术修复, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f754215915bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967232, encodeId=8027196e232c6, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=Clin Cancer Res：伊匹单抗+纳武单抗治疗脑转移的黑色素瘤的3期试验的长期随访结果, objectType=article, longId=216644, objectId=8f082166443f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f082166443f, replyNumber=0, likeNumber=73, createdTime=2022-07-28, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f082166443f, moduleTitle=Clin Cancer Res：伊匹单抗+纳武单抗治疗脑转移的黑色素瘤的3期试验的长期随访结果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8f082166443f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967229, encodeId=96a0196e229ee, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=Liver Cancer：卡瑞利珠单抗（Camrelizumab）治疗既往治疗进展的晚期肝细胞癌（HCC）患者的疗效：2期临床研究长期随访结果更新, objectType=article, longId=213622, objectId=76842136220f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76842136220f, replyNumber=0, likeNumber=138, createdTime=2022-03-28, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76842136220f, moduleTitle=Liver Cancer：卡瑞利珠单抗（Camrelizumab）治疗既往治疗进展的晚期肝细胞癌（HCC）患者的疗效：2期临床研究长期随访结果更新, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=76842136220f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967224, encodeId=9369196e2247a, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=JNNP:脑深部电刺激治疗神经性厌食症的长期随访, objectType=article, longId=208514, objectId=3c71208514c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c71208514c5, replyNumber=0, likeNumber=82, createdTime=2022-01-21, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c71208514c5, moduleTitle=JNNP:脑深部电刺激治疗神经性厌食症的长期随访, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3c71208514c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967225, encodeId=539d196e2258d, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=Int J Rheum Dis：长期随访结果表明手术仍然是强直性脊柱炎患者AL的更佳治疗方法, objectType=article, longId=210809, objectId=cf64210809c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf64210809c9, replyNumber=0, likeNumber=82, createdTime=2021-10-14, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf64210809c9, moduleTitle=Int J Rheum Dis：长期随访结果表明手术仍然是强直性脊柱炎患者AL的更佳治疗方法, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=cf64210809c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967223, encodeId=0446196e223cb, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=JCEM：诊断前和长期随访期间库欣综合征患者精神药物使用情况, objectType=article, longId=207152, objectId=03f020e15257, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03f020e15257, replyNumber=0, likeNumber=100, createdTime=2021-03-01, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03f020e15257, moduleTitle=JCEM：诊断前和长期随访期间库欣综合征患者精神药物使用情况, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=03f020e15257)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967227, encodeId=1634196e227ab, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=Eur J Cancer：奥沙利铂/卡培他滨联合放疗（OxCapRT）对比紫杉醇/卡铂联合放疗（CarPacRT）新辅助治疗对可切除食管腺癌的疗效和安全性：NeoSCOPE长期随访结果, objectType=article, longId=213266, objectId=96fd2132664f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96fd2132664f, replyNumber=0, likeNumber=73, createdTime=2022-06-07, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96fd2132664f, moduleTitle=Eur J Cancer：奥沙利铂/卡培他滨联合放疗（OxCapRT）对比紫杉醇/卡铂联合放疗（CarPacRT）新辅助治疗对可切除食管腺癌的疗效和安全性：NeoSCOPE长期随访结果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=96fd2132664f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967219, encodeId=5316196e21983, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=Diabetes Care：30年长期随访研究，年轻时多摄入叶酸或可降低糖尿病患病风险！, objectType=article, longId=199460, objectId=ca1a199460be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca1a199460be, replyNumber=0, likeNumber=84, createdTime=2021-05-16, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca1a199460be, moduleTitle=Diabetes Care：30年长期随访研究，年轻时多摄入叶酸或可降低糖尿病患病风险！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ca1a199460be)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

长期随访

2020-05-29

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

JCEM：有妊娠期糖尿病病史妇女发病率的长期随访

2022-11-13

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

Rheumatology：Janus激酶抑制剂和新型活动性疾病生物标记物在青少年皮肌炎中的长期随访结果

2022-08-05

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

JNNP：急性功能性假性卒中与轻度急性缺血性卒中的长期随访比较

2022-05-03

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

Acta Oncol：在临床试验之外接受治疗的慢性期老年慢性粒细胞白血病患者中一线达沙替尼的长期随访：一项现实生活中的队列观察研究

2022-05-18

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

Hypertension：长期随访血压变异性与亚临床肾损伤和蛋白尿的关系

2023-03-19

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

EuroIntervention：肾动脉超声消融治疗难治性高血压长期随访结果公布（RADIANCE-HTN SOLO研究）

2022-05-12

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

Clin Cancer Res：维奈托克单药治疗复发/难治性非霍奇金淋巴瘤的长期随访结果

2022-02-28

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

长期随访显示，肾脏替代治疗伴急性肾损伤的感染性休克烧伤患者仍可长期保留肾功能

2022-10-17

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

Diabetes Care：多篇新发糖尿病患者长期随访研究提示，早期控糖真的很重要！

2022-03-26

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

Clin Cancer Res：3期coBRIM研究| 威罗非尼+帕博西尼治疗BRAFV600+ 晚期黑色素瘤的长期随访结果

2021-12-05

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

Eur Urol Oncol：非肌层浸润性膀胱癌患者的长期随访及与主动监测失败相关的因素

2022-04-15

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

Clin Cancer Res: 考比替尼（cobimetinib）+ 维莫非尼（vemurafenib）对比安慰剂+ 维莫非尼（vemurafenib）治疗BRAF V600突变阳性转移性黑色素瘤的疗效和安全性: coBRIM研究5年长期随访结果

2021-07-27

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

Eur J Vas Endo Sur: 筛查中检测到主动脉直径25～29 mm的65岁男性建议长期随访主动脉扩张进程以确定是否需要手术修复

2022-05-28

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

Clin Cancer Res：伊匹单抗+纳武单抗治疗脑转移的黑色素瘤的3期试验的长期随访结果

2022-07-28

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

Liver Cancer：卡瑞利珠单抗（Camrelizumab）治疗既往治疗进展的晚期肝细胞癌（HCC）患者的疗效：2期临床研究长期随访结果更新

2022-03-28

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

JNNP:脑深部电刺激治疗神经性厌食症的长期随访

2022-01-21

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

Int J Rheum Dis：长期随访结果表明手术仍然是强直性脊柱炎患者AL的更佳治疗方法

2021-10-14

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

JCEM：诊断前和长期随访期间库欣综合征患者精神药物使用情况

2021-03-01

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

Eur J Cancer：奥沙利铂/卡培他滨联合放疗（OxCapRT）对比紫杉醇/卡铂联合放疗（CarPacRT）新辅助治疗对可切除食管腺癌的疗效和安全性：NeoSCOPE长期随访结果

2022-06-07

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

Diabetes Care：30年长期随访研究，年轻时多摄入叶酸或可降低糖尿病患病风险！

2021-05-16

科室
- - 订阅+
  - 更多科室
工具
服务